Pulse Biosciences Inc. has announced the issuance of inducement stock options to four newly hired employees, allowing them to purchase a total of 8,300 shares of company common stock. Approved by the independent Compensation Committee, these options are in line with Nasdaq Listing Rule 5635(c)(4) and are part of the company's 2017 Inducement Equity Incentive Plan. Each option has an exercise price of $17.13 per share, matching the closing price on May 19, 2025. The options will vest over four years, with a quarter of each award vesting annually, contingent on ongoing employment with Pulse Biosciences.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。